Allogene Therapeutics, Inc. (ALLO)
2.40
-0.07
(-2.83%)
USD |
NASDAQ |
Mar 13, 16:00
2.35
-0.05
(-2.08%)
After-Hours: 20:00
Allogene Therapeutics Total Liabilities (Quarterly) : 123.36M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 899.65M |
| Inovio Pharmaceuticals, Inc. | 51.59M |
| Vaxart, Inc. | 98.28M |
| Capricor Therapeutics, Inc. | -- |
| Agenus, Inc. | 514.76M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 415.90M |
| Shareholders Equity (Quarterly) | 292.54M |
| Debt to Equity Ratio | 0.2846 |
| Current Ratio | 7.927 |
| Net Debt Paydown Yield | 0.60% |